Petr Baranov, M.D., Ph.D.

Harvard Medical School

Assistant Professor of Ophthalmology

Schepens Eye Research Institute of Mass. Eye and Ear

Assistant Scientist

Research Summary

Center/Research Area Affiliations

Biography

An internationally trained scientist, Dr. Baranov is committed to the development of stem-cell based and molecular therapies for blinding diseases. His lab is spearheading the transplantation of stem-cell derived retinal ganglion cells in animal models of Glaucoma. They have demonstrated that it is possible to produce functional RGCs from stem cells and successfully engraft them into the diseased retina. Now they combine the advancements in stem cell biology with tissue engineering and imaging tools to address major hurdles in RGC replacement. He also works on collaborative projects, that explore neuroprotection and disease modeling.

Download his CV [PDF] for more information.

Education

2007: MSc, MD, Medicine, Medical cybernetics, Russian State Medical University (RSMU)

2011: PhD, Cell Biology, Ophthalmology, RSMU, Research Institute for Eye Diseases, Russian Academy of Medical Sciences

Postgraduate Training

2014: Postdoctoral fellowship, Retinal regeneration/tissue engineering, Schepens Eye Research Institute of Mass. Eye and Ear

Academic Appointments

2017-present: Assistant Professor in Ophthalmology, Harvard Medical School

Professional Memberships

2010-present: International Society for Stem Cell Research

2011-present: Association for Research in Vision and Ophthalmology

2015-present: International Society for Eye Research

Honors

2011: Brazilian Council of Ophthalmology Award (with Caio Regatieri and Michael Young), Brazilian Council of Ophthalmology

2017: ARVO/Genentech AMD Fellowship

Publications

Selected Publications

View Dr. Baranov's publications on PubMed or Google Scholar.

  1. Oswald J., Baranov P. Regenerative medicine in the retina: from stem cells to cell replacement therapy. Ther Adv Ophthalmol. 2018 Apr 26;10:2515841418774433. eCollection 2018 Jan-Dec.
  2. Eriksen AZ, Eliasen R, Oswald J, Kempen PJ, Melander F, Andresen TL, Young M, Baranov P* and Urquhart AJ. Multifarious Biologic Loaded Liposomes that Stimulate the Mammalian Target of Rapamycin Signaling Pathway Show Retina Neuroprotection after Retina Damage. ACS Nano. 2018 Aug 28;12(8):7497-7508. Epub 2018 Jul 18.
  3. Baranov P, Tucker B, Young MJ. Low-oxygen culture conditions extend the multipotent properties of human retinal progenitor cellsTissue Eng Part A. 2014 May; 20(9-10):1465-75.
  4. Shen J, Xiao R, Bair J, Wang F, Vandenberghe LH, Dartt D, Baranov P and Ng YS. Novel engineered, membrane-localized variants of vascular endothelial growth factor (VEGF) protect retinal ganglion cells: a proof-of-concept study. Cell Death Dis. 2018 Oct 3;9(10):1018. 
  5. Alavi M., Baranov P. The ipsc-derived retinal tissue as a tool to study growth factor production in vitro. Adv Exp Med Biol. 2018;1074:619-624.